Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 05, 2026
DataAggregated Company Financials
Companies7
- 7D-2.4%
- 3M-0.001%
- 1Y-16.3%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.4%, driven by Oxford Nanopore Technologies declining 3.0%. The industry has fallen 16% in the last year. Looking forward, earnings are forecast to grow by 57% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 05 Jul 2026 | UK£1.4b | UK£323.1m | -UK£164,731,254.00 | 1274.4x | -8.4x | 4.3x |
| Tue, 02 Jun 2026 | UK£1.6b | UK£323.0m | -UK£166,018,254.00 | 1248.2x | -9.7x | 5x |
| Thu, 30 Apr 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -7.7x | 4x |
| Sat, 28 Mar 2026 | UK£1.3b | UK£324.0m | -UK£161,423,254.00 | 8.4x | -8.2x | 4.1x |
| Mon, 23 Feb 2026 | UK£1.6b | UK£304.7m | -UK£159,511,254.00 | 12.1x | -9.8x | 5.1x |
| Wed, 21 Jan 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.1x | -10.5x | 5.5x |
| Fri, 19 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 9x | -9x | 4.7x |
| Sun, 16 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.2x | -9.1x | 4.9x |
| Tue, 14 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 10x | -10x | 5.4x |
| Thu, 11 Sep 2025 | UK£1.9b | UK£313.5m | -UK£158,190,352.00 | 5.8x | -12x | 6.1x |
| Sat, 09 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.9x | -14.3x | 7.9x |
| Mon, 07 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.9x | -10.1x | 5.6x |
| Wed, 04 Jun 2025 | UK£1.5b | UK£319.5m | -UK£190,862,773.00 | 6.6x | -8x | 4.8x |
| Fri, 02 May 2025 | UK£1.7b | UK£314.0m | -UK£192,470,599.55 | 11.8x | -8.7x | 5.3x |
| Sun, 30 Mar 2025 | UK£1.5b | UK£315.7m | -UK£186,460,928.95 | 5.5x | -7.9x | 4.7x |
| Tue, 25 Feb 2025 | UK£1.7b | UK£306.4m | -UK£195,118,317.84 | 6.4x | -8.6x | 5.5x |
| Thu, 23 Jan 2025 | UK£2.2b | UK£307.3m | -UK£195,846,260.16 | 7.4x | -11.2x | 7.1x |
| Sat, 21 Dec 2024 | UK£2.0b | UK£306.5m | -UK£195,239,105.52 | 7.7x | -10.2x | 6.5x |
| Mon, 18 Nov 2024 | UK£1.8b | UK£305.8m | -UK£193,578,219.28 | 10.2x | -9.5x | 6x |
| Wed, 16 Oct 2024 | UK£1.9b | UK£304.4m | -UK£192,344,868.10 | 11.1x | -10.1x | 6.4x |
| Fri, 13 Sep 2024 | UK£2.0b | UK£302.0m | -UK£190,981,483.10 | 11.2x | -10.2x | 6.5x |
| Sun, 11 Aug 2024 | UK£1.8b | UK£296.8m | -UK£189,164,393.70 | 12.3x | -9.6x | 6.1x |
| Tue, 09 Jul 2024 | UK£1.6b | UK£295.5m | -UK£189,944,285.55 | 11.6x | -8.2x | 5.2x |
| Thu, 06 Jun 2024 | UK£1.6b | UK£295.5m | -UK£189,703,240.59 | 11.5x | -8.3x | 5.3x |
| Sat, 04 May 2024 | UK£1.6b | UK£292.8m | -UK£188,897,474.93 | 6902.8x | -8.3x | 5.3x |
| Mon, 01 Apr 2024 | UK£1.7b | UK£319.1m | -UK£191,403,096.81 | 69.8x | -9.1x | 5.5x |
| Wed, 28 Feb 2024 | UK£1.9b | UK£285.8m | -UK£189,183,580.01 | 6857.6x | -10.3x | 6.8x |
| Fri, 26 Jan 2024 | UK£2.7b | UK£450.2m | -UK£176,581,151.00 | 68.6x | -15.4x | 6.1x |
| Sun, 24 Dec 2023 | UK£3.1b | UK£450.0m | -UK£174,026,893.00 | 52.7x | -18.1x | 7x |
| Tue, 21 Nov 2023 | UK£3.1b | UK£455.7m | -UK£168,757,075.00 | 49.9x | -18.1x | 6.7x |
| Thu, 19 Oct 2023 | UK£2.8b | UK£458.7m | -UK£165,670,462.00 | 48.2x | -17.1x | 6.2x |
| Sat, 16 Sep 2023 | UK£3.1b | UK£440.6m | -UK£167,086,339.00 | 67.5x | -18.6x | 7.1x |
| Mon, 14 Aug 2023 | UK£3.3b | UK£476.2m | -UK£126,558,560.00 | 70.6x | -25.8x | 6.8x |
| Wed, 12 Jul 2023 | UK£3.0b | UK£476.1m | -UK£124,412,971.00 | 66.1x | -24.2x | 6.3x |
Price to Earnings Ratio
-24.2x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.61% | |
| Healthcare | 1.40% | |
| Life Sciences | -2.42% | |
| Clinical Research and Equipment | -2.42% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.071 | 3.6% +UK£1.7m | -33.5% | PS1x | |
| DXRX Diaceutics | UK£1.46 | 0.7% +UK£846.7k | 25.3% | PE1274.4x | |
| FAB Fusion Antibodies | UK£0.12 | 4.3% +UK£625.1k | 86.0% | PS9.4x |